Cargando…
New use for an old drug: Metformin and atrial fibrillation
Lal and colleagues(1) reported an integrative approach—combining transcriptomics, iPSCs, and epidemiological evidence—to identify and repurpose metformin, a main first-line medication for the treatment of type 2 diabetes, as an effective risk reducer for atrial fibrillation.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798075/ https://www.ncbi.nlm.nih.gov/pubmed/36543101 http://dx.doi.org/10.1016/j.xcrm.2022.100875 |